| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | — |
100% | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 4,000 | ₹280,000 |
| Retail (Max — 13 Lots) | 13 | 26,000 | ₹1,820,000 |
| S-HNI (Min — 14 Lots) | 14 | 28,000 | ₹1,960,000 |
| B-HNI (Min — 68 Lots) | 68 | 136,000 | ₹9,520,000 |
Aptus Pharma Ltd. is proposing an IPO on BSE SME under the SME category.
Opens 23 Sep 2025, closes 25 Sep 2025. Listing: 03 Oct 2025. Apply via ASBA or UPI.
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Aptus Pharma Ltd. IPO is subscribed 1.00 times by Sep 25, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Aptus Pharma Ltd. IPO retail category is subscribed 1.00 times as of 25 Sep 2025. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 23 Sep 2025 and closes 25 Sep 2025. Min investment: ₹140,000 (1 lot = 2,000 shares). UPI mandate: 5:00 PM on 25 Sep 2025.
The Aptus Pharma Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 01 Oct 2025. Refunds: on 02 Oct 2025.
The Aptus Pharma Ltd. IPO listing date is 03 Oct 2025, Friday. Listed on: BSE SME. Issue price: ₹70. Estimated listing: ₹70. GMP: NIL.
The Aptus Pharma Ltd. IPO closes on 25 Sep 2025, Thursday. UPI mandate: 5:00 PM on 25 Sep 2025. Allotment: 01 Oct 2025. Listing: 03 Oct 2025.